← SynDRA
LMP-744
SynDRA canonical compound SYN0004416 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
| Primary target(s) | TOP1 |
| Mechanism of action | topoisomerase inhibitor |
| Indication | ovarian cancer |
| Disease area | oncology |
All known targets
Mechanisms of action (all sources)
Cross-references
Synonyms
- Lmp744
- Topoisomerase-1 inhibitor lmp744
- MJ-III-65
- NSC-706743
- NSC-706744
- LMP744
- LMP744 free base
- UNII-29BY7HQV0T
- 29BY7HQV0T
- NCI60_037977
- CHEMBL126159
- 308246-52-8 (free base)
- 6-(3-((2-hydroxyethyl)amino)propyl)-2,3-dimethoxy-5H-[1,3]dioxolo[4',5':5,6]indeno[1,2-c]isoquinoline-5,12(6H)-dione
- AC1L9FIC
- SCHEMBL4162998
- DTXSID30327954
- BCP34017
- EX-A3021
- BDBM50237809
- HY-U00248
- NSC706743
- CS-7432
- Q27894415
- 20-[3-(2-Hydroxyethylamino)propyl]-15,16-dimethoxy-5,7-dioxa-20-azapentacyclo[10.8.0.02,10.04,8.013,18]icosa-1(12),2,4(8),9,13,15,17-heptaene-11,19-dione
- 5H-(1,3)Dioxolo(5,6)indeno(1,2-C)isoquinoline-5,12(6H)-dione, 6-(3-((2-hydroxyethyl)amino)propyl)-2,3-dimethoxy-
- 5H-[1,6]indeno[1,2-c]isoquinoline- 5,12(6H)-dione,6-[3-[(2-hydroxyethyl)amino]propyl]-2,3-dimethoxy-
- 6-[3-(2-Hydroxyethyl)aminopropyl]-5,11-diketo-2,3-dimethoxy-8,9-(methylenedioxy)- 11H-indeno[1,2-c]isoquinoline
- orb1709250
- SCHEMBL29620329
- IMA24652
- AKOS040733616
- AC-35733
- MS-28221
- G17167
- T11872
- LMP744 hydrochloride
- orb1309471
Look up LMP-744 in the interactive SynDRA portal →